Radiation Therapy (XRT)

RADIATION5 trials

Sponsors

M.D. Anderson Cancer Center, Duke University, Wake Forest University Health Sciences, Abramson Cancer Center at Penn Medicine

Conditions

Anal CancerBrain TumorElbow FractureGlioblastomaGliosarcomaMalignant GliomaProstate Cancer

Phase 2

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

CompletedNCT00093379

M.D. Anderson Cancer CenterAnal Cancer

Start: 2004-04-30End: 2012-07-31Updated: 2023-04-18

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

CompletedNCT00597402

Duke UniversityBrain Tumor, Glioblastoma, Gliosarcoma

Start: 2007-07-31End: 2013-05-31Updated: 2014-05-07

Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma

CompletedNCT01004874

Duke UniversityGlioblastoma, Gliosarcoma, Malignant Glioma

Start: 2009-12-30End: 2021-11-02Updated: 2022-04-13

Unknown Phase

Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma

TerminatedNCT00991887

Wake Forest University Health SciencesElbow Fracture

Start: 2005-09-30End: 2010-07-31Updated: 2022-04-21

Proton Therapy for High Risk Prostate Cancer

WithdrawnNCT01811810

Abramson Cancer Center at Penn MedicineProstate Cancer

Start: 2013-03-31End: 2014-04-30Updated: 2019-04-23